Zheng Quan Zhi Xing·2025-06-09 12:24Core Viewpoint - The legal opinion issued by Beijing Yongxing Law Firm confirms that the 2025 Restricted Stock Incentive Plan of Baolingbao Biological Co., Ltd. has obtained the necessary approvals and complies with relevant regulations [4][8]. Group 1: Approval and Authorization - The company has completed the necessary procedures for the approval of the incentive plan, including discussions at the sixth board meeting and the issuance of relevant opinions by the remuneration and assessment committee [5][6]. - The plan has been publicly disclosed, and no objections were raised during the public notice period [6][8]. Group 2: Specifics of the Grant - The grant date for the incentive plan is set for June 9, 2025, with a grant price of 3.92 RMB per share for 10.35 million shares to 50 eligible participants [8]. - The conditions for granting the restricted stock include compliance with various financial and regulatory requirements, ensuring that the company and the participants do not fall under any disqualifying circumstances [9]. Group 3: Conclusion - The legal opinion concludes that all necessary approvals and authorizations have been obtained, and the grant date, recipients, and pricing are in accordance with the applicable regulations [8][9].